Factors affecting the efficacy of human leukocyte antigen‐selected platelet provision: A large retrospective study in the U nited K ingdom
Transfusion Medicine · 2025
DOI: 10.1111/tme.13123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion Medicine, 2025. Verfasst von W M Howell und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Service Development, NHS Blood and Transplant (NHSBT), Newcastle Centre, Newcastle, UK. Hauptthemen laut MEDLINE: Platelet Transfusion, HLA Antigens, Blood Platelets, ABO Blood-Group System. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: NHS Blood and Transplant.
Abstract (Originalsprache)
Background
A large, retrospective study was designed to interrogate current NHS Blood and Transplant (NHSBT) HLA matching strategies for the provision of HLA selected platelets (HLA SP) and to determine whether additional factors such as ABO blood group matching, patient diagnosis, patient and/or donor age, sex, ethnicity, age of platelet unit at transfusion and possibly seasonal variation also play a role in transfusion efficacy. Materials and Methods Data for 56 640 HLA SP transfusions over a 3‐year period were collected. Transfusions with missing data for any factor under consideration were excluded, resulting in a cohort of 13 044 transfusions for analysis. Univariable and multivariable regression models were used to determine if any factors influenced an increase in platelet count of ≥10 × 10 9 /L. A stepwise logistic regression was applied, such that each influential factor was adjusted for effects on other factors included in the study.
Results
HLA match grade was confirmed as a significant factor in transfusion efficacy, with ABO mismatched units 20% less likely to give an adequate platelet increment (≥10 × 10 9 /L). Platelet donor age, gender and ethnicity were not significant. Conversely, patient diagnosis, ethnicity, gender and age showed significant associations with platelet increments. Some seasonal variation in efficacy of platelet transfusion was also demonstrated.
Conclusion
This study has demonstrated the efficacy of HLA SP transfusions in refractory patients with a wide range of diagnoses, the importance of HLA match grade, plus the marginal effect of ABO matching. A wide range of donor‐related factors was excluded, while a number of patient‐related factors were identified, requiring more extensive investigation in ongoing and independent studies, with implications for donor registry, clinical and laboratory practices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathology Service Development, NHS Blood and Transplant (NHSBT), Newcastle Centre, Newcastle, UK.
- Histocompatibility & Immunogenetics, NHSBT Colindale Centre, London, UK.
- Statistics and Clinical Research, NHSBT Stoke Gifford Centre, Bristol, UK.
ORCID-Profile: C J Brown
Förderung
- NHS Blood and Transplant
Zitieren
APA
Howell, W. M., Quaye, L., Mumford, L., Phillips, S., Mepani, K., Mohamed, S., & Brown, C. J. (2025). Factors affecting the efficacy of human leukocyte antigen‐selected platelet provision: A large retrospective study in the U nited K ingdom. Transfusion Medicine. https://doi.org/10.1111/tme.13123
Vancouver
Howell WM, Quaye L, Mumford L, Phillips S, Mepani K, Mohamed S, et al. Factors affecting the efficacy of human leukocyte antigen‐selected platelet provision: A large retrospective study in the U nited K ingdom. Transfusion Medicine. 2025. doi:10.1111/tme.13123
BibTeX
@article{Howell2025,
author = {Howell, W M and Quaye, L and Mumford, L and Phillips, S and Mepani, K and Mohamed, S and Brown, C J},
title = {Factors affecting the efficacy of human leukocyte antigen‐selected platelet provision: A large retrospective study in the U nited K ingdom},
journal = {Transfusion Medicine},
year = {2025},
doi = {10.1111/tme.13123}
}
EUVIMED